Skip to main content
OpenTrials

Clinical trial condition

Uterine Neoplasms

Explore clinical trials studying Uterine Neoplasms. Study availability and eligibility vary by location and protocol.

2,256 public trials 565 recruiting studies
Refine in advanced search Browse all conditions

Uterine Neoplasms trial results

Recruiting

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

NCT07262619

Conditions
Advanced Solid Tumors, Endometrial Cancer, Endometrial Neoplasms, +21 more
Locations
  • Morristown Medical Center Morristown, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center (MSKCC) New York, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • GenesisCare North Shore (Oncology) Saint Leonards, New South Wales, Australia
View Trial Details
Recruiting

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

NCT07216105

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +48 more
Locations
  • University of Southern California La Jolla, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States
  • Thomas Jefferson University, Sidney Kimmel Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

A Study of VET3-TGI in Patients With Solid Tumors

NCT06444815

Conditions
Adenocarcinoma, Adenoma, Bronchial Neoplasms, +56 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health Orange, California, United States
  • University of Miami Miami, Florida, United States
  • Community Health Network Indianapolis, Indiana, United States
View Trial Details
Recruiting

A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha

NCT06547840

Conditions
Advanced Endometrial Cancer, Advanced Ovarian Cancer, Breast Diseases, +20 more
Locations
  • Bristol Haematology and Oncology Centre Bristol, United Kingdom
  • Edinburgh Cancer Research Centre Edinburgh, United Kingdom
  • Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom
  • Cambridge University - Addenbrooke's Hospital London, United Kingdom
View Trial Details
Recruiting

A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

NCT04486352

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Medstar Georgetown Cancer Institute Washington D.C., District of Columbia, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
View all 21 locations
View Trial Details
Recruiting

Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama

NCT04093388

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • Cahaba Medical Care - West End Birmingham, Alabama, United States
  • Cahaba Medical Care - Ensley Birmingham, Alabama, United States
  • Cahaba Medical Care Centreville, Alabama, United States
View Trial Details
Recruiting

SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer

NCT07256236

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Fujian Medical University Affiliated Second Hospital Fuzhou, Fujian, China
  • Zhangzhou Affiliated Hospital of Fujian Medical University Zhangzhou, Fujian, China
  • Zhujiang Hospital of Southern Medical University Guangzhou, Guangdong, China
View all 14 locations
View Trial Details

Related conditions